Cargando…
Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cells
Oligodendrocyte progenitor cells (OPCs) are responsible for remyelination in the central nervous system (CNS) in health and disease. For patients with multiple sclerosis (MS), remyelination is not always successful, and the mechanisms differentiating successful from failed remyelination are not well...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314832/ https://www.ncbi.nlm.nih.gov/pubmed/35266197 http://dx.doi.org/10.1002/glia.24165 |
_version_ | 1784754412797820928 |
---|---|
author | Zveik, Omri Fainstein, Nina Rechtman, Ariel Haham, Nitzan Ganz, Tal Lavon, Iris Brill, Livnat Vaknin‐Dembinsky, Adi |
author_facet | Zveik, Omri Fainstein, Nina Rechtman, Ariel Haham, Nitzan Ganz, Tal Lavon, Iris Brill, Livnat Vaknin‐Dembinsky, Adi |
author_sort | Zveik, Omri |
collection | PubMed |
description | Oligodendrocyte progenitor cells (OPCs) are responsible for remyelination in the central nervous system (CNS) in health and disease. For patients with multiple sclerosis (MS), remyelination is not always successful, and the mechanisms differentiating successful from failed remyelination are not well‐known. Growing evidence suggests an immune role for OPCs, in addition to their regenerative role; however, it is not clear if this helps or hinders the regenerative process. We studied the effect of cerebrospinal fluid (CSF) from relapsing MS (rMS) and progressive MS (pMS) patients on primary OPC differentiation and immune gene expression and function. We observed that CSF from either rMS or pMS patients has a differential effect on the ability of mice OPCs to differentiate into mature oligodendrocytes and to express immune functions. CSF of pMS patients impaired differentiation into mature oligodendrocytes. In addition, it led to decreased major histocompatibility complex class (MHC)‐II expression, tumor necrosis factor (TNF)‐α secretion, nuclear factor kappa‐B (NFκB) activation, and less activation and proliferation of T cells. Our findings suggest that OPCs are not only responsible for remyelination, but they may also play an active role as innate immune cells in the CNS. |
format | Online Article Text |
id | pubmed-9314832 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93148322022-07-30 Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cells Zveik, Omri Fainstein, Nina Rechtman, Ariel Haham, Nitzan Ganz, Tal Lavon, Iris Brill, Livnat Vaknin‐Dembinsky, Adi Glia Research Articles Oligodendrocyte progenitor cells (OPCs) are responsible for remyelination in the central nervous system (CNS) in health and disease. For patients with multiple sclerosis (MS), remyelination is not always successful, and the mechanisms differentiating successful from failed remyelination are not well‐known. Growing evidence suggests an immune role for OPCs, in addition to their regenerative role; however, it is not clear if this helps or hinders the regenerative process. We studied the effect of cerebrospinal fluid (CSF) from relapsing MS (rMS) and progressive MS (pMS) patients on primary OPC differentiation and immune gene expression and function. We observed that CSF from either rMS or pMS patients has a differential effect on the ability of mice OPCs to differentiate into mature oligodendrocytes and to express immune functions. CSF of pMS patients impaired differentiation into mature oligodendrocytes. In addition, it led to decreased major histocompatibility complex class (MHC)‐II expression, tumor necrosis factor (TNF)‐α secretion, nuclear factor kappa‐B (NFκB) activation, and less activation and proliferation of T cells. Our findings suggest that OPCs are not only responsible for remyelination, but they may also play an active role as innate immune cells in the CNS. John Wiley & Sons, Inc. 2022-03-09 2022-06 /pmc/articles/PMC9314832/ /pubmed/35266197 http://dx.doi.org/10.1002/glia.24165 Text en © 2022 The Authors. GLIA published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Research Articles Zveik, Omri Fainstein, Nina Rechtman, Ariel Haham, Nitzan Ganz, Tal Lavon, Iris Brill, Livnat Vaknin‐Dembinsky, Adi Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cells |
title | Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cells |
title_full | Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cells |
title_fullStr | Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cells |
title_full_unstemmed | Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cells |
title_short | Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cells |
title_sort | cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cells |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314832/ https://www.ncbi.nlm.nih.gov/pubmed/35266197 http://dx.doi.org/10.1002/glia.24165 |
work_keys_str_mv | AT zveikomri cerebrospinalfluidofprogressivemultiplesclerosispatientsreducesdifferentiationandimmunefunctionsofoligodendrocyteprogenitorcells AT fainsteinnina cerebrospinalfluidofprogressivemultiplesclerosispatientsreducesdifferentiationandimmunefunctionsofoligodendrocyteprogenitorcells AT rechtmanariel cerebrospinalfluidofprogressivemultiplesclerosispatientsreducesdifferentiationandimmunefunctionsofoligodendrocyteprogenitorcells AT hahamnitzan cerebrospinalfluidofprogressivemultiplesclerosispatientsreducesdifferentiationandimmunefunctionsofoligodendrocyteprogenitorcells AT ganztal cerebrospinalfluidofprogressivemultiplesclerosispatientsreducesdifferentiationandimmunefunctionsofoligodendrocyteprogenitorcells AT lavoniris cerebrospinalfluidofprogressivemultiplesclerosispatientsreducesdifferentiationandimmunefunctionsofoligodendrocyteprogenitorcells AT brilllivnat cerebrospinalfluidofprogressivemultiplesclerosispatientsreducesdifferentiationandimmunefunctionsofoligodendrocyteprogenitorcells AT vaknindembinskyadi cerebrospinalfluidofprogressivemultiplesclerosispatientsreducesdifferentiationandimmunefunctionsofoligodendrocyteprogenitorcells |